Limited clinical value of multiple blood markers in the diagnosis of ischemic stroke

Clinical Biochemistry

Volumn 46, Issue 9, 2013, Pages 710-715

  An, Se A ^a   Kim, Jinkwon ^a   Kim, Ok Joon ^a   Kim, Jin Kyeoung ^a   Kim, Nam Keun ^a   Song, Jihwan ^a   Oh, Seung Hun ^a  

^a CHA University   (South Korea)

Author keywords

Blood marker; Diagnosis; Ischemic stroke

Indexed keywords

BIOLOGICAL MARKER; FATTY ACID BINDING PROTEIN; GELATINASE B; GLIAL FIBRILLARY ACIDIC PROTEIN; HEART TYPE FATTY ACID BINDING PROTEIN; INTERLEUKIN 6; NEUROGLOBIN; NEURON SPECIFIC ENOLASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN S100B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VISININ; VISININ LIKE PROTEIN 1;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HUMAN; MACROGLIA; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; BRAIN INFARCTION; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; ROC CURVE; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT;

EID: 84877832602     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.02.005     Document Type: Article

References (38)

1. Katzan I.L., Hammer M.D., Hixson E.D., Furlan A.J., Abou-Chebl A., Nadzam D.M. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol 2004, 61:346-350.
2. Whiteley W., Tseng M.C., Sandercock P. Blood biomarkers in the diagnosis of ischemic stroke: a systematic review. Stroke 2008, 39:2902-2909.
3. Laskowitz D.T., Kasner S.E., Saver J., Remmel K.S., Jauch E.C. Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study. Stroke 2009, 40:77-85.
4. Harbison J., Massey A., Barnett L., Hodge D., Ford G.A. Rapid ambulance protocol for acute stroke. Lancet 1999, 353:1935.
5. Kothari R.U., Pancioli A., Liu T., Brott T., Broderick J. Cincinnati Prehospital Stroke Scale: reproducibility and validity. Ann Emerg Med 1999, 33:373-378.
6. Kidwell C.S., Starkman S., Eckstein M., Weems K., Saver J.L. Identifying stroke in the field. Prospective validation of the Los Angeles Prehospital Stroke Screen (LAPSS). Stroke 2000, 31:71-76.
7. Whiteley W., Wardlaw J., Dennis M., Lowe G., Rumley A., Sattar N., et al. Blood biomarkers for the diagnosis of acute cerebrovascular diseases: a prospective cohort study. Cerebrovasc Dis 2011, 32:141-147.
8. Vanni S., Polidori G., Pepe G., Chiarlone M., Albani A., Pagnanelli A., et al. Use of biomarkers in triage of patients with suspected stroke. J Emerg Med 2011, 40:499-505.
9. Sibon I., Rouanet F., Meissner W., Orgogozo J.M. Use of the Triage Stroke Panel in a neurologic emergency service. Am J Emerg Med 2009, 27:558-562.
10. Adams H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24:35-41.
11. Ahmad O., Wardlaw J., Whiteley W.N. Correlation of levels of neuronal and glial markers with radiological measures of infarct volume in ischaemic stroke: a systematic review. Cerebrovasc Dis 2012, 33:47-54.
12. Laterza O.F., Modur V.R., Crimmins D.L., Olander J.V., Landt Y., Lee J.M., et al. Identification of novel brain biomarkers. Clin Chem 2006, 52:1713-1721.
13. Shang A., Zhou D., Wang L., Gao Y., Fan M., Wang X., et al. Increased neuroglobin levels in the cerebral cortex and serum after ischemia-reperfusion insults. Brain Res 2006, 1078:219-226.
14. Whiteley W., Jackson C., Lewis S., Lowe G., Rumley A., Sandercock P., et al. Association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort study. Stroke 2011, 42:10-16.
15. Montaner J., Alvarez-Sabin J., Molina C., Angles A., Abilleira S., Arenillas J., et al. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke 2001, 32:1759-1766.
16. Reynolds M.A., Kirchick H.J., Dahlen J.R., Anderberg J.M., McPherson P.H., Nakamura K.K., et al. Early biomarkers of stroke. Clin Chem 2003, 49:1733-1739.
17. Lynch J.R., Blessing R., White W.D., Grocott H.P., Newman M.F., Laskowitz D.T. Novel diagnostic test for acute stroke. Stroke 2004, 35:57-63.
18. Laskowitz D.T., Blessing R., Floyd J., White W.D., Lynch J.R. Panel of biomarkers predicts stroke. Ann N Y Acad Sci 2005, 1053:30.
19. Wang Q., Tang X.N., Yenari M.A. The inflammatory response in stroke. J Neuroimmunol 2007, 184:53-68.
20. Kerr R., Stirling D., Ludlam C.A. Interleukin 6 and haemostasis. Br J Haematol 2001, 115:3-12.
21. Suzuki S., Tanaka K., Nogawa S., Nagata E., Ito D., Dembo T., et al. Temporal profile and cellular localization of interleukin-6 protein after focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1999, 19:1256-1262.
22. Whiteley W., Jackson C., Lewis S., Lowe G., Rumley A., Sandercock P., et al. Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med 2009, 6:e1000145.
23. Jauch E.C., Lindsell C., Broderick J., Fagan S.C., Tilley B.C., Levine S.R. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke 2006, 37:2508-2513.
24. Jonsson H., Johnsson P., Birch-Iensen M., Alling C., Westaby S., Blomquist S. S100B as a predictor of size and outcome of stroke after cardiac surgery. Ann Thorac Surg 2001, 71:1433-1437.
25. Foerch C., Singer O.C., Neumann-Haefelin T., du Mesnil R., de Rochemont H., Steinmetz M.Sitzer Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction. Arch Neurol 2005, 62:1130-1134.
26. Korfias S., Stranjalis G., Papadimitriou A., Psachoulia C., Daskalakis G., Antsaklis A., et al. Serum S-100B protein as a biochemical marker of brain injury: a review of current concepts. Curr Med Chem 2006, 13:3719-3731.
27. Montaner J., Rovira A., Molina C.A., Arenillas J.F., Ribo M., Chacon P., et al. Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke. J Cereb Blood Flow Metab 2003, 23:1403-1407.
28. Sotgiu S., Zanda B., Marchetti B., Fois M.L., Arru G., Pes G.M., et al. Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur J Neurol 2006, 13:505-513.
29. Montaner J., Mendioroz M., Ribo M., Delgado P., Quintana M., Penalba A., et al. A panel of biomarkers including caspase-3 and D-dimer may differentiate acute stroke from stroke-mimicking conditions in the emergency department. J Int Med 2011, 270:166-174.
30. Nor A.M., Davis J., Sen B., Shipsey D., Louw S.J., Dyker A.G., et al. The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument. Lancet Neurol 2005, 4:727-734.
31. Davalos A., Toni D., Iweins F., Lesaffre E., Bastianello S., Castillo J. Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European cooperative acute stroke study (ECASS) I. Stroke 1999, 30:2631-2636.
32. Dassan P., Keir G., Brown M.M. Criteria for a clinically informative serum biomarker in acute ischaemic stroke: a review of S100B. Cerebrovasc Dis 2009, 27:295-302.
33. Wunderlich M.T., Hanhoff T., Goertler M., Spener F., Glatz J.F., Wallesch C.W., et al. Release of brain-type and heart-type fatty acid-binding proteins in serum after acute ischaemic stroke. J Neurol 2005, 252:718-724.
34. Montaner J., Perea-Gainza M., Delgado P., Ribo M., Chacon P., Rosell A., et al. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 2008, 39:2280-2287.
35. Meng R., Ji X. Plasma biomarker and stroke. Cerebrovasc Dis 2011, 32:406.
36. Missler U., Wiesmann M., Friedrich C., Kaps M. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 1997, 28:1956-1960.
37. Welsh P., Barber M., Langhorne P., Rumley A., Lowe G.D., Stott D.J. Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke. Cerebrovasc Dis 2009, 27:247-253.
38. Montaner J., Molina C.A., Monasterio J., Abilleira S., Arenillas J.F., Ribó M., et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 2003, 107:598-603.